BioLife Solutions (STU:BJX1) Net Issuance of Preferred Stock : €0.00 Mil (TTM As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is BioLife Solutions Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

BioLife Solutions's net issuance of preferred for the three months ended in Mar. 2025 was €0.00 Mil. The number is 0, which means that BioLife Solutions has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

BioLife Solutions's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2025 was €0.00 Mil.

BioLife Solutions Net Issuance of Preferred Stock Historical Data

The historical data trend for BioLife Solutions's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLife Solutions Net Issuance of Preferred Stock Chart

BioLife Solutions Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

BioLife Solutions Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

BioLife Solutions Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

BioLife Solutions Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of BioLife Solutions's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

BioLife Solutions Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioLife Solutions Inc (STU:BJX1) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

BLFS:USA

Address

3303 Monte Villa Parkway, Suite 310, Bothell, WA, USA, 98021

Website

https://www.biolifesolutions.com

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

BioLife Solutions Headlines

No Headlines